IL1F10 and myocardial infarction: In addition, after the injection of recombinant IL-38, there was ventricular remodeling post-MI, restricted inflammatory responses, attenuated myocardial injury, and diminished myocardial fibrosis through affecting (altering) the phenotype of DCs.